Veröffentlichungen
2011
Buck K, Vrieling A, Flesch-Janys D, Chang-Claude J.
Dietary patterns and the risk of postmenopausal breast cancer in a German case-control study.
Cancer Causes Control 2011 February;22(2):273-82.
Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, Apicella C, Smith LD, Hammet F, Southey MC, Van 't Veer LJ, de Groot R, Smit VT, Fasching PA, Beckmann MW, Jud S, Ekici AB, Hartmann A, Hein A, Schulz-Wendtland R, Burwinkel B, Marme F, Schneeweiss A, Sinn HP, Sohn C, Tchatchou S, Bojesen SE, Nordestgaard BG, Flyger H, Orsted DD, Kaur-Knudsen D, Milne RL, Pérez JI, Zamora P, Rodríguez PM, Benítez J, Brauch H, Justenhoven C, Ko YD; The Genica Network, Hamann U, Fischer HP, Brüning T, Pesch B, Chang-Claude J, Wang-Gohrke S, Bremer M, Karstens JH, Hillemanns P, Dörk T, Nevanlinna HA, Heikkinen T, Heikkilä P, Blomqvist C, Aittomäki K, Aaltonen K, Lindblom A, Margolin S, Mannermaa A, Kosma VM, Kauppinen JM, Kataja V, Auvinen P, Eskelinen M, Soini Y, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Holland H; kConFab; AOCS, Lambrechts D, Claes B, Vandorpe T, Neven P, Wildiers H, Flesch-Janys D, Hein R, Löning T, Kosel M, Fredericksen ZS, Wang X, Giles GG, Baglietto L, Severi G, McLean C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Grenaker Alnæs G, Kristensen V, Børresen-Dale AL, Hunter DJ, Hankinson SE, Andrulis IL, Marie Mulligan A, O'Malley FP, Devilee P, Huijts PE, Tollenaar RA, Van Asperen CJ, Seynaeve CS, Chanock SJ, Lissowska J, Brinton L, Peplonska B, Figueroa J, Yang XR, Hooning MJ, Hollestelle A, Oldenburg RA, Jager A, Kriege M, Ozturk B, van Leenders GJ, Hall P, Czene K, Humphreys K, Liu J, Cox A, Connley D, Cramp HE, Cross SS, Balasubramanian SP, Reed MW, Dunning AM, Easton DF, Humphreys MK, Caldas C, Blows F, Driver K, Provenzano E, Lubinski J, Jakubowska A, Huzarski T, Byrski T, Cybulski C, Gorski B, Gronwald J, Brennan P, Sangrajrang S, Gaborieau V, Shen CY, Hsiung CN, Yu JC, Chen ST, Hsu GC, Hou MF, Huang CS, Anton-Culver H, Ziogas A, Pharoah PD, Garcia-Closas M.
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: Findings from the Breast Cancer Association Consortium.
Hum Mol Genet. 2011.
Li J, Seibold P, Chang-Claude J, Flesch-Janys D, Liu J, Czene K, Humphreys K, Hall P.
Coffee consumption modifies risk of estrogen-receptor negative breast cancer.
Breast Cancer Res. 2011;13:R49.
Liedtke S, Schmidt ME, Becker S, Kaaks R, Zaineddin AK, Buck K, Flesch-Janys D, Wahrendorf J, Chang-Claude J, Steindorf K.
Physical activity and endogenous sex hormones in postmenopausal women: to what extent are observed associations confounded or modified by BMI?.
Cancer Causes Control 2011 January;22(1):81-9.
Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Van ', V, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Mulligan AM, O'Malley FP, Weerasooriya N, John EM, Beckmann MW, Hartmann A, Weihbrecht SB, Wachter DL, Jud SM, Loehberg CR, Baglietto L, English DR, Giles GG, McLean CA, Severi G, Lambrechts D, Vandorpe T, Weltens C, Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, Dork T, Bremer M, Meyer A, Karstens JH, Ay A, Park-Simon TW, Hillemanns P, rias Perez JI, Menendez RP, Zamora P, Benitez J, Ko YD, Fischer HP, Hamann U, Pesch B, Bruning T, Justenhoven C, Brauch H, Eccles DM, Tapper WJ, Gerty SM, Sawyer EJ, Tomlinson IP, Jones A, Kerin M, Miller N, McInerney N, nton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le ML, Kolonel LN, Lindblom A, Margolin S, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Gorski B, Gronwald J, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Kriege M, Tilanus-Linthorst MM, Collee M, Wang-Gohrke S, Pylkas K, Jukkola-Vuorinen A, Mononen K, Grip M, Hirvikoski P, Winqvist R, Mannermaa A, Kosma VM, Kauppinen J, Kataja V, Auvinen P, Soini Y, Sironen R, Bojesen SE, Orsted DD, Kaur-Knudsen D, Flyger H, Nordestgaard BG, Holland H, Chenevix-Trench G, Manoukian S, Barile M, Radice P, Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gaborieau V, Devilee P, Huijts PE, Tollenaar RA, Seynaeve C, Dite GS, Apicella C, Hopper JL, Hammet F, Tsimiklis H, Smith LD, Southey MC, Humphreys MK, Easton D, Pharoah P, Sherman ME, Garcia-Closas M.
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies..
J Natl Cancer Inst 2011 February 2;103(3):250-63.
Zaineddin AK, Vrieling A, Buck K et al.
Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and HER2 receptor status.
Int J Cancer. 2011.
2010
Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D, Peock S, Cook M, Oliver C, Frost D, Eccles D, Evans DG, Eeles R, Izatt L, Chu C, Douglas F, Paterson J, Stoppa-Lyonnet D, Houdayer C, Mazoyer S, Giraud S, Lasset C, Remenieras A, Caron O, Hardouin A, Berthet P, Hogervorst FB, Rookus MA, Jager A, van den OA, Hoogerbrugge N, van der Luijt RB, Meijers-Heijboer H, Gomez Garcia EB, Devilee P, Vreeswijk MP, Lubinski J, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Gorski B, Cybulski C, Spurdle AB, Holland H, Goldgar DE, John EM, Hopper JL, Southey M, Buys SS, Daly MB, Terry MB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Preisler-Adams S, Arnold N, Niederacher D, Sutter C, Domchek SM, Nathanson KL, Rebbeck T, Blum JL, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Blank SV, Friedman E, Kaufman B, Laitman Y, Milgrom R, Andrulis IL, Glendon G, Ozcelik H, Kirchhoff T, Vijai J, Gaudet MM, Altshuler D, Guiducci C, Loman N, Harbst K, Rantala J, Ehrencrona H, Gerdes AM, Thomassen M, Sunde L, Peterlongo P, Manoukian S, Bonanni B, Viel A, Radice P, Caldes T, de la HM, Singer CF, Fink-Retter A, Greene MH, Mai PL, Loud JT, Guidugli L, Lindor NM, Hansen TV, Nielsen FC, Blanco I, Lazaro C, Garber J, Ramus SJ, Gayther SA, Phelan C, Narod S, Szabo CI, Benitez J, Osorio A, Nevanlinna H, Heikkinen T, Caligo MA, Beattie MS, Hamann U, Godwin AK, Montagna M, Casella C, Neuhausen SL, Karlan BY, Tung N, Toland AE, Weitzel J, Olopade O, Simard J, Soucy P, Rubinstein WS, Arason A, Rennert G, Martin NG, Montgomery GW, Chang-Claude J, Flesch-Janys D, Brauch H, Severi G, Baglietto L, Cox A, Cross SS, Miron P, Gerty SM, Tapper W, Yannoukakos D, Fountzilas G, Fasching PA, Beckmann MW, Dos SS, I, Peto J, Lambrechts D, Paridaens R, Rudiger T, Forsti A, Winqvist R, Pylkas K, Diasio RB, Lee AM, Eckel-Passow J, Vachon C, Blows F, Driver K, Dunning A, Pharoah PP, Offit K, Pankratz VS, Hakonarson H, Chenevix-Trench G, Easton DF, Couch FJ.
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.
Nat Genet 2010 October;42(10):885-92.
Barnes BB, Steindorf K, Hein R, Flesch-Janys D, Chang-Claude J.
Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.
Cancer Epidemiol 2010 December 13.
Hentschel S, Heinz J, Schmid-Hopfner S, Obi N, Vettorazzi E, Chang-Claude J, Flesch-Janys D.
The impact of menopausal hormone therapy on the incidence of different breast cancer types--data from the Cancer Registry Hamburg 1991-2006.
Cancer Epidemiol 2010 October;34(5):639-43.
Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benitez J, rias Perez JI, Zamora MP, Malats N, Dos SS, I, Gibson LJ, Fletcher O, Johnson N, nton-Culver H, Ziogas A, Figueroa J, Brinton L, Sherman ME, Lissowska J, Hopper JL, Dite GS, Apicella C, Southey MC, Sigurdson AJ, Linet MS, Schonfeld SJ, Freedman DM, Mannermaa A, Kosma VM, Kataja V, Auvinen P, Andrulis IL, Glendon G, Knight JA, Weerasooriya N, Cox A, Reed MW, Cross SS, Dunning AM, Ahmed S, Shah M, Brauch H, Ko YD, Bruning T, Lambrechts D, Reumers J, Smeets A, Wang-Gohrke S, Hall P, Czene K, Liu J, Irwanto AK, Chenevix-Trench G, Holland H, Giles GG, Baglietto L, Severi G, Bojensen SE, Nordestgaard BG, Flyger H, John EM, West DW, Whittemore AS, Vachon C, Olson JE, Fredericksen Z, Kosel M, Hein R, Vrieling A, Flesch-Janys D, Heinz J, Beckmann MW, Heusinger K, Ekici AB, Haeberle L, Humphreys MK, Morrison J, Easton DF, Pharoah PD, Garcia-Closas M, Goode EL, Chang-Claude J.
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.
Breast Cancer Res 2010;12(6):R110.
Seibold P, Hein R, Schmezer P, Hall P, Liu J, Dahmen N, Flesch-Janys D, Popanda O, Chang-Claude J.
Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk.
Int J Cancer 2010 November 12.
Steindorf K, Chang-Claude J, Flesch-Janys D, Schmidt ME.
Determinants of sports, cycling, walking and overall leisure-time physical activity among postmenopausal women in Germany.
Public Health Nutr 2010 November;13(11):1905-14.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy
Int J Cancer. 2010 Jun 15; 126(12):2935-46.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women
Breast Cancer Res Treat. 2010 Apr;120(3):727-36.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism
Breast Cancer Res Treat. 2010 Apr;120(3):737-44.
2009
Abbas S, Brauch H, Chang-Claude J, Dünnebier T, Flesch-Janys D, Hamann U, Hein R, Justenhoven C, Salazar R.
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy
Int J Cancer. 2009 Sep 8.
The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women
Breast Cancer Res Treat. 2009 Aug 12.
The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism
Breast Cancer Res Treat. 2009 Aug 12.
Schmidt ME, Chang-Claude J, Slanger T, Obi N, Flesch-Janys D, Steindorf K.
Physical activity and postmenopausal breast cancer: effect modification by other breast cancer risk factors
Methods Inf Med. 2009;48(5):444-50.
Barnes BB, Chang-Claude J, Flesch-Janys D, Kinscherf R, Schmidt M, Slanger T, Bonaterra G, Steindorf K.
Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status
Cancer Causes Control. 2009 Jul 12.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.
Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women
Breast Cancer Res Treat. 2010 Jan;119(2):463-74.
Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T, Kämpjärvi K, Aaltonen K, Nevanlinna H, Bogdanova N, Coinac I, Schürmann P, Dörk T, Bartram CR, Schmutzler RK, Tchatchou S, Burwinkel B, Brauch H, Torres D, Hamann U, Justenhoven C, Ribas G, Arias JI, Benitez J, Bojesen SE, Nordestgaard BG, Flyger HL, Peto J, Fletcher O, Johnson N, Dos Santos Silva I, Fasching PA, Beckmann MW, Strick R, Ekici AB, Broeks A, Schmidt MK, van Leeuwen FE, Van't Veer LJ, Southey MC, Hopper JL, Apicella C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter DJ, Kraft P, Cox DG, Hankinson SE, Seynaeve C, Vreeswijk MP, Tollenaar RA, Devilee P, Chanock S, Lissowska J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Titus-Ernstoff L, Trentham Dietz A, Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J; Australian Ovarian Cancer Study Group, Chenevix-Trench G, Spurdle AB, Beesley J, Pharoah PD, Easton DF, Garcia-Closas M; Breast Cancer Association Consortium.
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1610-6.
Obi N, Chang-Claude J, Berger J, Braendle W, Slanger T, Schmidt M, Steindorf K, Ahrens W, Flesch-Janys D.
The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study
Cancer Epidemiol Biomarkers Prev. 2009; 18(8). August 2009
Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D.
Menopausal Hormone Therapy and Risk of Clinical Breast Cancer Subtypes
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96
Alison M. Dunning, Catherine S. Healey, Caroline Baynes, Ana-Teresa Maia, Serena, Scollen, Ana Vega, Raquel Rodri´guez, Nuno L. Barbosa-Morais, Bruce A.J. Ponder for SEARCH Yen-Ling Low, Sheila Bingham for EPIC, Christopher A. Haiman, Loic Le Marchand for MEC, Annegien Broeks, Marjanka K. Schmidt for ABCS, John Hopper, Melissa Southey for ABCFS, Matthias W. Beckmann, Peter A. Fasching for BBCC, Julian Peto, Nichola Johnson for BBCS, Stig E. Bojesen, Børge Nordestgaard for CGPS, Roger L. Milne, Javier Benitez for CNIO-BCS, Ute Hamann, Yon Ko for GENICA, Rita K. Schmutzler, Barbara Burwinkel for GC-HBOC, Peter Schürmann, Thilo Dörk for HABCS, Tuomas Heikkinen, Heli Nevanlinna for HEBCS, Annika Lindblom, Sara Margolin for KARBAC, Arto Mannermaa, Veli-Matti Kosma for KBCS, Xiaoqing Chen, Amanda Spurdle for kConFab and the AOCS Management Group, Jenny Change-Claude, Dieter Flesch-Janys for MARIE, Fergus J. Couch, Janet E. Olson for MCBCS, Gianluca Severi, Laura Baglietto for MCCS, Anne-Lise Børresen-Dale, Vessela Kristensen for NBCS, David J. Hunter, Susan E. Hankinson for NHS, Peter Devilee, Maaike Vreeswijk for ORIGO, Jolanta Lissowska, Louise Brinton for PBCS, Jianjun Liu, Per Hall for SASBAC, Daehee Kang, Keun-Young Yoo for SEBCS, Chen-Yang Shen, Jyh-Cherng Yu for TWBCS, Hoda Anton-Culver, Argyrios Ziogoas for UCIBCS, Alice Sigurdson, Jeff Struewing for USRTS,Douglas F. Easton, Montserrat Garcia-Closas, Manjeet K. Humphreys, Jonathan Morrison, Paul D.P. Pharoah, Karen A. Pooley, and Georgia Chenevix-Trench for BCAC
Association of ESR1 gene tagging SNPs with breast cancer risk.
Human Molecular Genetics 2009; 18(6): 1131-1139
2008
Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Berger J, Chang-Claude J.
Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy
Int J Cancer. 2008 Aug 15;123(4):933-41.
Schmidt ME, Steindorf K, Mutschelknauss E, Slanger T, Kropp S, Obi N, Flesch-Janys D, Chang-Claude J.
Physical activity and postmenopausal breast cancer: effect modification by breast cancer subtypes and effective periods in life
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3402-10. Epub 2008 Nov 24.
Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J
The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin d status
Cancer Epidemiol Biomarkers Prev 2008; 17(6):1339-1343.
Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J
Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk
Breast Cancer Res 2008; 10(2):R31.
Frank B, Wiestler M, Kropp S, Hemminki K, Spurdle AB, Sutter C, Wappenschmidt B, Chen X, Beesley J, Hopper JL, Meindl A, Kiechle M, Slanger T, Bugert P, Schmutzler RK, Bartram CR, Flesch-Janys D, Mutschelknauss E, Ashton K, Salazar R, Webb E, Hamann U, Brauch H, Justenhoven C, Ko YD, Bruning T, Silva IS, Johnson N, Pharoah PP, Dunning AM, Pooley KA, Chang-Claude J, Easton DF, Peto J, Houlston R, Chenevix-Trench G, Fletcher O, Burwinkel B:
Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis.
J Natl Cancer Inst 2008; 100(6):437-442.
Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, Bojesen SE, Nordestgaard BG, Axelsson CK, Arias JI, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Zamora P, Brauch H, Justenhoven C, Hamann U, Ko YD, Bruening T, Haas S, Dork T, Schurmann P, Hillemanns P, Bogdanova N, Bremer M, Karstens JH, Fagerholm R, Aaltonen K, Aittomaki K, von SK, Blomqvist C, Mannermaa A, Uusitupa M, Eskelinen M, Tengstrom M, Kosma VM, Kataja V, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Australian Ovarian Cancer Management Group, Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer, Devilee P, van Asperen CJ, Jacobi CE, Tollenaar RA, Huijts PE, Klijn JG, Chang-Claude J, Kropp S, Slanger T, Flesch-Janys D, Mutschelknauss E, Salazar R, Wang-Gohrke S, Couch F, Goode EL, Olson JE, Vachon C, Fredericksen ZS, Giles GG, Baglietto L, Severi G, Hopper JL, English DR, Southey MC, Haiman CA, Henderson BE, Kolonel LN, Le ML, Stram DO, Hunter DJ, Hankinson SE, Cox DG, Tamimi R, Kraft P, Sherman ME, Chanock SJ, Lissowska J, Brinton LA, Peplonska B, Klijn JG, Hooning MJ, Meijers-Heijboer H, Collee JM, van den OA, Uitterlinden AG, Liu J, Lin LY, Yuqing L, Humphreys K, Czene K, Cox A, Balasubramanian SP, Cross SS, Reed MW, Blows F, Driver K, Dunning A, Tyrer J, Ponder BA, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gabrieau V, Sigurdson A, Doody M, Struewing JP, Alexander B, Easton DF, Pharoah PD
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
PLoS Genet 2008; 4(4):e1000054.
2007
Kropp, S., Terboven, T., Hedicke, J., Mutschelknauss, E. J., Slanger, T., Braendle, W., Berger, J., Chang-Claude, J., and Flesch-Janys, D.
Good agreement between physician reports and questionnaire hormone therapy data in a German case-control study
Journal of Clinical Epidemiology 2007; Vol.60 (12):1280-1287
Slanger, T., Mutschelknaus, E. J., Kropp, S., Braendle, W., Flesch-Janys, D., and Chang-Claude, J.
Test-retest reliability of self-reported reproductive and lifestyle data in the context of a German case-control study on breast cancer and postmenopausal hormone therapy
Annals of Epidemiology 2007 Dec;17(12):993-8. Epub 2007 Sep 14
Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss E, Flesch-Janys D, Chang-Claude J
Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer - results of a large case-control study.
Carcinogenesis 2007.
2004
Flesch-Janys D, Kropp S, Terboven T, Hedicke J, Mutschelknauss EJ, Slanger T, Braendle W, Berger J, Chang-Claude J.
Validation study on self-reported use and physician report of hormone therapy.
Journal für Menopause 11[2], 37. 2004
2002
Braendle, W., Berger, J., Flesch-Janys, D., Hentschel, S., and Chang-Claude, J
Presentation of the first German epidemiologic study on HRT and breast cancer
Climacteric ,2002; 5 Sup 1:118-118.
Braendle W, Berger J, Flesch-Janys D, Hentschel S, Bastert G
Vorstellung der ersten deutschen epidemiologischen Studie zu HRT und Mammakarzinom
J Menopause 2002; 9(2):29-38.
Flesch-Janys D, Braendle W, Berger J, Hentschel S, Mutschelknauss EJ
MARIE-Studie startet in Hamburg.
Hamburger Ärzteblatt 2002.
Flesch-Janys D, Braendle W:
Deutsche epidemiologische Studie zu HRT und Mammakarzinom.
Gyno-Panorama 2002;(3):17-24.